J. Goldman & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-31,701	Closed	-$2.61M	–	472
2024 Q2	$2.61M	Sell	31,701 -101,682	-76%	-$8.47M	0.07%	224
2024 Q1	$11.6M	Buy	133,383 +128,549	+2,659%	+$11.5M	0.38%	87
2023 Q4	$466K	Buy	+4,834	New	+$428K	0.02%	266
2021 Q1	–	Sell	-5,811	Closed	-$510K	–	440
2020 Q4	$510K	Buy	+5,811	New	+$461K	0.03%	277
2020 Q3	–	Sell	-2,183	Closed	-$269K	–	312
2020 Q2	$269K	Buy	+2,183	New	+$217K	0.02%	240
2016 Q4	–	Sell	-41,500	Closed	-$3.84M	–	302
2016 Q3	$3.84M	Buy	+41,500	New	+$3.91M	0.22%	132
2016 Q2	–	Sell	-11,900	Closed	-$982K	–	331
2016 Q1	$982K	Buy	+11,900	New	+$968K	0.06%	224